Natera Announces Completion of Signatera™ Analysis from the CALGB (Alliance)/SWOG 80702 Randomized, Phase III Clinical Trial in Colorectal Cancer

Go back to Natera Announces Completion of Signatera™ Analysis from the CALGB (Alliance)/SWOG 80702 Randomized, Phase III Clinical Trial in Colorectal Cancer
(NASDAQ: NTRA) Delayed: 328.18 +0.51 (0.16%)
Previous Close $327.67    52 Week High $13.80 
Open $323.92    52 Week Low $6.52 
Day High $329.05    P/E N/A 
Day Low $323.42    EPS $0.00 
Volume 968,222